Objectives To describe medium‐to long‐term follow‐up of patients undergoing device
closure of patent foramen ovale (PFO) for stroke or transient ischemic attack (TIA) …

Background Transcatheter closure of patent foramen ovale (PFO) is a widespread
procedure. However the “quest” for the ideal device is still ongoing. Here we present the …

Aims: Although routinely used, limited data are available regarding the long-term outcome
after patent foramen ovale (PFO) closure using the HELEX® Occluder system. The aim of …

Use of the NobleStitch™ EL for the treatment of patients with residual right‐to‐left shunt following
device closure of PFO - Chaudhry‐Waterman - 2021 - Clinical Case Reports - Wiley Online Library …

Background A number of devices are available for percutaneous closure of a clinically
significant patent foramen ovale (PFO). The new GORE® septal occluder (GSO) is a nonself …

Background: Percutaneous, mechanical closure of defects of the atrial septum fails to
completely resolve shunting in up to 20% of cases. Little is known about the factors …

Transcatheter closure of an atrial septal defect (ASD) is considered the standard of care for
most of the patients with secundum ASD. The existence of multiple or fenestrated ASD may …

Introduction The management of patients with residual right‐to‐left shunt (rRLS) after
percutaneous patent foramen ovale (PFO) closure is debated. The aim of this study was to …

Background: A number of devices are available for percutaneous closure of a clinically
significant patent foramen ovale (PFO). The new GOREV R septal occluder (GSO) is a …

Abstract The Gore REDUCE Clinical Study is a prospective, randomized, open-label,
multinational, multicenter evaluation comparing antiplatelet medical management plus …